IL42594A - Cancer associated polypeptide antigen,its preparation,its detection and immunizing compositions containing it - Google Patents
Cancer associated polypeptide antigen,its preparation,its detection and immunizing compositions containing itInfo
- Publication number
- IL42594A IL42594A IL42594A IL4259473A IL42594A IL 42594 A IL42594 A IL 42594A IL 42594 A IL42594 A IL 42594A IL 4259473 A IL4259473 A IL 4259473A IL 42594 A IL42594 A IL 42594A
- Authority
- IL
- Israel
- Prior art keywords
- capa
- process according
- gel
- resulting
- fraction
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 14
- 239000000427 antigen Substances 0.000 title claims abstract 13
- 102000036639 antigens Human genes 0.000 title claims abstract 13
- 108091007433 antigens Proteins 0.000 title claims abstract 13
- 229920001184 polypeptide Polymers 0.000 title claims abstract 13
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract 13
- 239000000203 mixture Substances 0.000 title claims abstract 12
- 206010028980 Neoplasm Diseases 0.000 title claims abstract 9
- 201000011510 cancer Diseases 0.000 title claims 5
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 239000000463 material Substances 0.000 claims abstract 14
- 239000007787 solid Substances 0.000 claims abstract 7
- 239000007864 aqueous solution Substances 0.000 claims abstract 6
- 239000002808 molecular sieve Substances 0.000 claims abstract 6
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000002253 acid Substances 0.000 claims abstract 4
- 238000004587 chromatography analysis Methods 0.000 claims abstract 4
- 238000001914 filtration Methods 0.000 claims abstract 4
- 239000007788 liquid Substances 0.000 claims abstract 3
- 239000011324 bead Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims abstract 2
- 238000005194 fractionation Methods 0.000 claims abstract 2
- 239000003960 organic solvent Substances 0.000 claims abstract 2
- 238000001556 precipitation Methods 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 31
- 239000000499 gel Substances 0.000 claims 16
- 239000000839 emulsion Substances 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 4
- 229920002401 polyacrylamide Polymers 0.000 claims 4
- 229920005654 Sephadex Polymers 0.000 claims 3
- 238000010521 absorption reaction Methods 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 238000000227 grinding Methods 0.000 claims 3
- 150000002500 ions Chemical class 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 229920001817 Agar Polymers 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 241001494479 Pecora Species 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000008272 agar Substances 0.000 claims 2
- 239000011543 agarose gel Substances 0.000 claims 2
- 210000000601 blood cell Anatomy 0.000 claims 2
- 230000003247 decreasing effect Effects 0.000 claims 2
- 238000010828 elution Methods 0.000 claims 2
- 238000002523 gelfiltration Methods 0.000 claims 2
- 239000004816 latex Substances 0.000 claims 2
- 229920000126 latex Polymers 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 239000011236 particulate material Substances 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 claims 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 229910000831 Steel Inorganic materials 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 239000002535 acidifier Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000000628 antibody-producing cell Anatomy 0.000 claims 1
- 239000006286 aqueous extract Substances 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 229910000278 bentonite Inorganic materials 0.000 claims 1
- 239000000440 bentonite Substances 0.000 claims 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 238000001574 biopsy Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 230000000536 complexating effect Effects 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 230000003297 denaturating effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 238000000265 homogenisation Methods 0.000 claims 1
- 229940124452 immunizing agent Drugs 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 210000002826 placenta Anatomy 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 238000013207 serial dilution Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000002798 spectrophotometry method Methods 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 239000010959 steel Substances 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27027372A | 1972-07-10 | 1972-07-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL42594A0 IL42594A0 (en) | 1973-08-29 |
| IL42594A true IL42594A (en) | 1976-08-31 |
Family
ID=23030635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL42594A IL42594A (en) | 1972-07-10 | 1973-06-25 | Cancer associated polypeptide antigen,its preparation,its detection and immunizing compositions containing it |
Country Status (22)
| Country | Link |
|---|---|
| JP (2) | JPS5817168B2 (no) |
| AR (1) | AR197243A1 (no) |
| AT (1) | AT336780B (no) |
| BE (1) | BE802126A (no) |
| BR (1) | BR7305142D0 (no) |
| CA (1) | CA1039650A (no) |
| CH (1) | CH617853A5 (no) |
| DD (2) | DD118946A5 (no) |
| DE (2) | DE2366609C2 (no) |
| DK (1) | DK139898B (no) |
| ES (1) | ES416726A1 (no) |
| FI (1) | FI60567C (no) |
| FR (1) | FR2191885B1 (no) |
| GB (2) | GB1443054A (no) |
| IL (1) | IL42594A (no) |
| IN (1) | IN138903B (no) |
| IT (1) | IT1009527B (no) |
| NL (1) | NL7309257A (no) |
| NO (1) | NO146338C (no) |
| SE (3) | SE440697B (no) |
| SU (1) | SU581842A3 (no) |
| ZA (1) | ZA734632B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132769A (en) * | 1974-10-30 | 1979-01-02 | Osther Kurt B | Cancer antigen, cancer therapy, and cancer diagnosis |
| US4146603A (en) * | 1977-02-18 | 1979-03-27 | Research Corporation | Tumor specific glycoproteins and method for detecting tumorigenic cancers |
| US4172124A (en) * | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
| JPS56145297A (en) * | 1980-04-11 | 1981-11-11 | Kureha Chem Ind Co Ltd | Preparative method of glycoprotein having immunosupressing activity |
| EP0087898A1 (en) * | 1982-02-22 | 1983-09-07 | Cancer Research Campaign Technology Limited | Antibodies and antigens useful in the diagnosis and treatment of cancer |
-
1973
- 1973-06-25 IN IN1473/CAL/73A patent/IN138903B/en unknown
- 1973-06-25 SE SE7308917A patent/SE440697B/xx unknown
- 1973-06-25 IL IL42594A patent/IL42594A/en unknown
- 1973-06-29 FI FI2099/73A patent/FI60567C/fi active
- 1973-07-03 DE DE2366609A patent/DE2366609C2/de not_active Expired
- 1973-07-03 NL NL7309257A patent/NL7309257A/xx not_active Application Discontinuation
- 1973-07-03 DE DE19732333740 patent/DE2333740A1/de active Granted
- 1973-07-06 CH CH988073A patent/CH617853A5/de not_active IP Right Cessation
- 1973-07-06 AR AR248979A patent/AR197243A1/es active
- 1973-07-06 DD DD186676*A patent/DD118946A5/xx unknown
- 1973-07-06 DD DD172110A patent/DD113918A5/xx unknown
- 1973-07-09 GB GB4980974A patent/GB1443054A/en not_active Expired
- 1973-07-09 AT AT600773A patent/AT336780B/de not_active IP Right Cessation
- 1973-07-09 CA CA175,995A patent/CA1039650A/en not_active Expired
- 1973-07-09 IT IT26346/73A patent/IT1009527B/it active
- 1973-07-09 ES ES416726A patent/ES416726A1/es not_active Expired
- 1973-07-09 NO NO2807/73A patent/NO146338C/no unknown
- 1973-07-09 DK DK380773AA patent/DK139898B/da not_active IP Right Cessation
- 1973-07-09 GB GB3263473A patent/GB1443053A/en not_active Expired
- 1973-07-10 BE BE133300A patent/BE802126A/xx not_active IP Right Cessation
- 1973-07-10 FR FR7325241A patent/FR2191885B1/fr not_active Expired
- 1973-07-10 SU SU7301949792A patent/SU581842A3/ru active
- 1973-07-10 JP JP48077839A patent/JPS5817168B2/ja not_active Expired
- 1973-07-10 BR BR5142/73A patent/BR7305142D0/pt unknown
- 1973-07-10 ZA ZA734632A patent/ZA734632B/xx unknown
-
1976
- 1976-09-06 SE SE7609837A patent/SE440597B/xx not_active IP Right Cessation
- 1976-09-06 SE SE7609836A patent/SE418186B/xx not_active IP Right Cessation
-
1981
- 1981-01-14 JP JP56003331A patent/JPS6018011B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2583030B2 (ja) | インヒビンに特異な抗体の製造法および抗血清 | |
| Geffen et al. | Immunohistochemical localization of protein components of catecholamine storage vesicles | |
| Kresina et al. | Isolation and characterization of basement membrane collagen from human placental tissue. Evidence for the presence of two genetically distinct collagen chains | |
| US4160019A (en) | Detection of cancer associated polypeptide antigen and preparation of antibodies thereto | |
| US20070128660A1 (en) | Methods for detecting weakly immunogenic analytes | |
| LÖFBERG et al. | Human brain cortical neurons contain y-trace. Rapid isolation, immunohistochemical and physicochemical characterization of human y-trace | |
| Kornguth et al. | Isolation and partial characterization of a tubulin-like protein from human and swine synaptosomal membranes | |
| US3672954A (en) | Process for preparing deprotenized blood extracts having a healing action and product obtained thereby | |
| US4402872A (en) | Protein and process for isolating it | |
| Joshi et al. | Properties of the progestagen-dependent protein of the human endometrium | |
| IL42594A (en) | Cancer associated polypeptide antigen,its preparation,its detection and immunizing compositions containing it | |
| KR850001770B1 (ko) | 인체 암 항원에 대한 특이항체의 제조방법 | |
| US4211766A (en) | Cancer associated polypeptide antigen compositions | |
| Larkin et al. | Production of antisera against electrophoretically separated relaxin and immunofluorescent localization of relaxin in the porcine corpus luteum | |
| US3409605A (en) | Concentration and purification of growth factor-placental origin (human) | |
| Håkanson et al. | Peptides with NH2-terminal tryptophan in adrenocorticotrophic hormone and melanocyte-stimulating hormone granules of adenohypophysis. | |
| Nishizawa et al. | Spectrophotometric assay, solubilization and purification of brain 2′: 3′-cyclic nucleotide 3′-phosphodiesterase | |
| NZ215887A (en) | Tissue extracts with antitumor properties and compositions of them | |
| Muszynska et al. | Chemical modification of carboxypeptidase A crystals. Nitration of tyrosine-248 | |
| Shome | Peptides of the hypothalamus | |
| US6222010B1 (en) | Urogenital carcinoma TLP peptides | |
| Tezuka et al. | A Novel Protein of Rat Epidermis—Haematoxylin Stain‐Positive Protein of Keratohyalin Granules as the Membrane Lining Protein of the Stratum Corneum— | |
| OHASHI et al. | Purification of toxohormone by DEAE-cellulose columnchromatography | |
| Ramselaar et al. | Non-immunological regression of dimethylbenz (A) anthracene-induced experimental keratoacanthomas in the rabbit | |
| Ebels et al. | A survey of some active sheep pineal fractions and a discussion on the possible significance of pteridines in those fractions in in vitro and in vivo assays |